|Bid||11,570.00 x 200|
|Ask||11,580.00 x 34100|
|Day's Range||11,570.00 - 11,650.00|
|52 Week Range||99.40 - 11,650.00|
|PE Ratio (TTM)||148,333.33|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
To keep his anxiety under control, Peter, a 35-year-old government employee, relied for nine years on a blue-and-white pill he popped every night before bed: Cymbalta, made by Eli Lilly & Co. When a generic ...
The bull market that kicked off in March 2009 should be on the front cover of AARP magazine. At age 8, the S&P 500 bull run is very old and very overvalued compared to its historical ratios. Given the less than stellar circumstances, how should you invest now?
GlaxoSmithKline plc (GSK) announced positive top-line results from a phase III revaccination study on its shingles vaccine candidate, Shingrix, in older patients.